Cancer screening rate in people with diabetes in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009.

Cancer screening rate in people with diabetes in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009.
复制标题

DOI:
10.4178/epih.e2017036
复制
发表时间:
2017
影响因子:
3.8
通讯作者:
Park B
Park B
中科院分区:
医学3区
文献类型:
--
作者:
Chuck KW;Hwang M;Choi KS;Suh M;Jun JK;Park B

文献摘要

被引文献

相似文献

研究糖尿病患者与非糖尿病患者的胃癌、乳腺癌和宫颈癌筛查率。使用的数据来自韩国国民健康和营养检查调查(2007-2009年)。40岁及以上的无癌症男性和30岁及以上的无癌症女性被包括在内。比较了糖尿病患者和非糖尿病患者的终生筛查率和定期筛查率。与没有糖尿病的人相比,糖尿病患者接受过癌症筛查的人数更少(胃癌为53.5%比59.5%,p<0.001;乳腺癌60.5%比71.5%,p<0.001;宫颈癌49.1比59.6%,p<0.001)。与非糖尿病患者相比,糖尿病患者接受推荐的胃癌(38.9%比42.9%,p<0.001)、乳腺癌(38.8%比44.6%,p<0.001)和宫颈癌(35.1%比51.2%,p<0.001)的推荐筛查更少。在根据社会经济因素进行的亚组分析中,在大多数社会经济亚组中,糖尿病人群的终生筛查率和推荐筛查率都较低。在调整了社会经济因素的多因素分析中,糖尿病患者对胃癌和宫颈癌的终生筛查率较低(优势比[OR]为0.8;95%可信区间[CI],0.7至0.9和OR为0.7;95%CI,0.6至0.9);乳腺癌和宫颈癌的常规筛查率较低(OR为0.7;95%CI,0.6至0.9和OR为0.7;95%CI,0.5至0.9)。糖尿病患者的癌症筛查率低于非糖尿病患者。考虑到糖尿病患者的癌症风险较高,应努力提高这一高危人群的筛查率。
To investigate the screening rates for gastric, breast, and cervical cancer in people with diabetes compared with people without diabetes. Data from the Korea National Health and Nutrition Examination Survey (2007-2009) were used. Cancer-free men who were 40 years old and over and cancer-free women who were 30 years old and over were included. The lifetime screening rate and regular screening rate were compared in people with and without diabetes. Fewer people with diabetes than people without diabetes had ever received cancer screening (53.5 vs. 59.5%, p<0.001 for gastric cancer; 60.5 vs. 71.5%, p<0.001 for breast cancer; and 49.1 vs. 59.6%, p<0.001 for cervical cancer). Fewer people with diabetes than people without diabetes received the recommended screenings for gastric cancer (38.9 vs. 42.9%, p<0.001), breast cancer (38.8 vs. 44.6%, p<0.001), and cervical cancer (35.1 vs. 51.2%, p<0.001). In subgroup analyses according to socioeconomic factors, the lifetime and recommended screening rates were lower in the diabetic population in most socioeconomic subgroups. In the multivariate analysis adjusted for socioeconomic factors, people with diabetes showed lower lifetime screening rates for gastric and cervical cancer (odds ratio [OR], 0.8; 95% confidence interval [CI], 0.7 to 0.9 and OR, 0.7; 95% CI, 0.6 to 0.9), and lower regular screening rates for breast and cervical cancer (OR, 0.7; 95% CI, 0.6 to 0.9 and OR, 0.7; 95% CI, 0.5 to 0.9). The cancer screening rate in people with diabetes was lower than in people without diabetes. Considering the higher cancer risk in people with diabetes, efforts to increase the screening rate in this high-risk population should be implemented.